Senior insider sale
President and CEO at AMICUS THERAPEUTICS, INC. — senior position signals high conviction
$2.21M
182.10K shares
What this filing means
CAMPBELL BRADLEY L plans to sell 182.10K shares of AMICUS THERAPEUTICS, INC. valued at approximately $2.21M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/20/2026ACC: 0001950047-26-000555
DirectorOfficer· President and CEO
Since Mar 2026
182.10K
Shares to sell
$2.21M
Approx. market value
75K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
1/20/2026
75KTotal acquired75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/20/2026 | Exercise of Stock Options Cash | 75K | — |
| Total | 75K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
7.50K
Market value
$82.5K
12/15/2025
—Completed
Units to sell
70.43K
Market value
$763.5K
12/15/2025
—Completed
Units to sell
14.59K
Market value
$146.0K
12/1/2025
—Completed
Units to sell
14.59K
Market value
$146.5K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
75K
Market value
$1.07M
1/20/2026
Total
Units
182.10K
Value
$2.21M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2025 | 7.50K | $82.5K | — | Completed |
12/15/2025 | 70.43K | $763.5K | — | Completed |
12/1/2025 | 14.59K | $146.0K | — | Completed |
11/24/2025 | 14.59K | $146.5K | — | Completed |
| Planned — Approximate Date | ||||
1/20/2026 | 75K | $1.07M | NASDAQ | Planned |
| Total | 182.10K | $2.21M | ||